Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

PAVMPAVmed Inc.

Nasdaq · CIK 0001624326
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC3841 Surgical & Medical Instruments & Apparatus
FY end1231
XBRL facts385

Identity from submissions API

NamePAVmed Inc.
CIK0001624326
TickersPAVM
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC3841 Surgical & Medical Instruments & Apparatus
EIN471214177
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(212) 949-4319
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)1

Former names

  • PAXmed Inc. (2014-11-19T05:00:00.000Z → 2015-03-26T04:00:00.000Z)
Business address
360 MADISON AVENUE
25TH FLOOR
NEW YORK
NY
10017
NY
Mailing address
360 MADISON AVENUE
25TH FLOOR
NEW YORK
NY
10017
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

693 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 10-Q FORM 10-Q 0001437749-26-037174 001-37685 261561103 34 10525271 1 1
2026-11-13 8-K 8-K 2.02,7.01,9.01 0001493152-26-051544 001-37685 261549078 34 306185 1 1
2026-11-03 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001094891-26-000317 005-89489 261518230 34 7407
2026-10-23 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001094891-26-000308 005-89489 261482701 34 9174
2026-10-22 8-K 8-K 1.01,3.03,9.01 0001493152-26-048138 001-37685 261479535 34 207240 1 1
2026-09-10 8-K 8-K 1.01,9.01 0001493152-26-042021 001-37685 261369300 34 576772 1 1
2026-09-10 424B5 424B5 0001493152-26-042020 333-283994 261369256 33 659483
2026-08-14 8-K 8-K 2.02,7.01,9.01 0001493152-26-038072 001-37685 261277580 34 307676 1 1
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001094891-26-000279 005-89489 261275543 34 9844
2026-08-13 10-Q FORM 10-Q 0001437749-26-027733 001-37685 261274757 34 10291215 1 1
2026-07-30 S-8 S-8 0001493152-26-035296 333-297819 261219752 33 280876 1 1
2026-06-24 8-K 8-K 5.02,5.07,9.01 0001493152-26-029944 001-37685 261116682 34 219028 1 1
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001011438-26-000349 005-89489 26990044 34 19921
2026-05-15 8-K 8-K 2.02,7.01,9.01 0001493152-26-023352 001-37685 26982410 34 313811 1 1
2026-05-14 10-Q FORM 10-Q 0001437749-26-017121 001-37685 26980473 34 9005323 1 1
2026-05-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000728083-26-000004 005-89489 26979693 34 9562
2026-05-11 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-022317 005-89489 26964806 34 12323
2026-04-30 DEF 14A DEF 14A 0001493152-26-020705 001-37685 26929470 34 4490664 1 1
2026-04-30 DEFA14A DEFA14A 0001493152-26-020713 001-37685 26926933 34 1375121
2026-04-30 ARS ARS 0001493152-26-020710 001-37685 26926919 34 2403553
2026-04-29 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001387 333-295202 26919618 33 1857
2026-04-29 424B3 424B3 0001493152-26-019594 333-295202 26916242 33 342199
2026-04-27 CORRESP filename1.htm 0001493152-26-019087 12135
2026-04-24 UPLOAD filename1.pdf 0000000000-26-004245 333-295202 147799
2026-04-21 S-3 S-3 0001493152-26-018158 333-295202 26876564 33 769250 1 1
2026-04-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-043174 005-89489 26860873 34 12628
2026-04-13 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001094891-26-000191 5080
2026-04-13 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001094891-26-000187 4256
2026-04-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002128174-26-000001 005-89489 26856886 34 8405
2026-04-09 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001094891-26-000179 005-89489 26852939 34 31325
2026-04-08 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001094891-26-000176 005-89489 26849601 34 10866
2026-04-08 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001094891-26-000174 005-89489 26849275 34 7332
2026-04-06 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001094891-26-000168 5783
2026-04-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001094891-26-000165 8535
2026-04-03 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001094891-26-000162 005-89489 26839251 34 10485
2026-04-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001094891-26-000157 5053
2026-04-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001094891-26-000155 5014
2026-04-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001094891-26-000153 5004
2026-04-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001094891-26-000151 9356
2026-04-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001094891-26-000149 4968
2026-04-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001094891-26-000147 5012
2026-04-03 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001094891-26-000145 005-89489 26838700 34 9511
2026-04-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001094891-26-000144 5007
2026-04-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001094891-26-000142 5065
2026-04-02 S-8 S-8 0001493152-26-014732 333-294840 26829905 33 282342 1 1
2026-04-02 S-8 S-8 0001493152-26-014731 333-294839 26829906 33 277154 1 1
2026-03-30 8-K 8-K 2.02,7.01,9.01 0001493152-26-013477 001-37685 26810052 34 306926 1 1
2026-03-27 8-K 8-K 5.02,5.03,5.07,9.01 0001493152-26-013264 001-37685 26808567 34 228322 1 1
2026-03-27 10-K FORM 10-K 0001437749-26-010115 001-37685 26808450 34 14434889 1 1
2026-02-24 DEF 14A DEF 14A 0001493152-26-007884 001-37685 26671769 34 1759372
2026-02-17 D xslFormDX01/primary_doc.xml 06b 0001094891-26-000056 021-573645 26636738 33 13184
2026-02-13 PRE 14A PRE 14A 0001493152-26-006762 001-37685 26634276 34 1605627
2026-02-09 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001094891-26-000053 15218
2026-02-04 8-K 8-K 1.01,1.02,2.03,3.02,3.03,5.03,7.01,9.01 0001493152-26-005023 001-37685 26596096 34 1189990 1 1
2026-01-23 8-K 8-K 8.01,9.01 0001493152-26-003409 001-37685 26556906 34 201677 1 1
2025-12-30 8-K 8-K 3.03,5.03,7.01,9.01 0001493152-25-029510 001-37685 251611368 34 258141 1 1
2025-12-05 8-K 8-K 5.07,9.01 0001493152-25-026368 001-37685 251553152 34 210510 1 1
2025-11-13 8-K 8-K 2.02,7.01,9.01 0001493152-25-022122 001-37685 251475486 34 307898 1 1
2025-11-12 10-Q 10-Q 0001493152-25-022017 001-37685 251474351 34 9670952 1 1
2025-10-31 DEF 14A DEF 14A 0001493152-25-020379 001-37685 251440525 34 1902913
2025-10-20 PRE 14A PRE 14A 0001493152-25-018644 001-37685 251403976 34 1903414
2025-10-10 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001493152-25-017859 38018
2025-10-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001094891-25-000046 4874
2025-10-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001094891-25-000045 4887
2025-10-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001094891-25-000044 4868
2025-10-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001094891-25-000043 4878
2025-10-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001094891-25-000042 4876
2025-10-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001094891-25-000041 4911
2025-10-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001094891-25-000040 4957
2025-10-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001094891-25-000039 8447
2025-10-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001094891-25-000038 4927
2025-09-11 8-K 8-K 8.01,9.01 0001493152-25-013048 001-37685 251307362 34 251843 1 1
2025-08-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001766157-25-000004 005-89489 251217968 34 6823
2025-08-14 8-K 8-K 2.02,7.01,9.01 0001641172-25-023729 001-37685 251214438 34 310135 1 1
2025-08-14 10-Q 10-Q 0001493152-25-011923 001-37685 251213709 34 8726956 1 1
2025-07-30 8-K 8-K 8.01,9.01 0001493152-25-011491 001-37685 251164007 34 206244 1 1
2025-07-28 S-8 forms-8.htm 0001493152-25-011458 333-288997 251155664 33 279014 1 1
2025-06-24 8-K 8-K 1.01,9.01 0001641172-25-016227 001-37685 251066731 34 210698 1 1
2025-06-18 8-K 8-K 5.02,5.07,9.01 0001641172-25-015612 001-37685 251057659 34 232665 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000728083-25-000007 005-89489 25950955 34 6662
2025-05-15 8-K 8-K 2.02,7.01,9.01 0001641172-25-010536 001-37685 25948901 34 292044 1 1
2025-05-15 10-Q 10-Q 0001641172-25-010433 001-37685 25948232 34 7661634 1 1
2025-05-09 DEFA14A DEFA14A 0001641172-25-009431 001-37685 25930144 34 129149
2025-04-30 DEFA14A DEFA14A 0001641172-25-007791 001-37685 25895590 34 3073003
2025-04-30 ARS ARS 0001641172-25-007786 001-37685 25895549 34 1639405
2025-04-30 DEF 14A DEF 14A 0001641172-25-007773 001-37685 25895466 34 3608215 1 1
2025-04-30 25-NSE xslF25X02/primary_doc.xml 0001354457-25-000363 001-37685 25895008 34 3092
2025-04-25 8-K form8-k.htm 4.01,9.01 0001641172-25-006250 001-37685 25874965 34 268835 1 1
2025-04-21 424B3 form424b3.htm 0001641172-25-005545 333-283994 25853167 33 270223
2025-04-18 PRE 14A formpre14a.htm 0001641172-25-005449 001-37685 25850872 34 3765191 1 1
2025-04-17 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001140 333-286442 25849169 33 1857
2025-04-17 8-K form8-k.htm 1.01,9.01 0001641172-25-005279 001-37685 25848283 34 622374 1 1
2025-04-17 424B5 form424b5.htm 0001641172-25-005271 333-283994 25848234 33 660529
2025-04-15 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001117 333-283994 25841116 33 1857
2025-04-15 CORRESP filename1.htm 0001641172-25-004716 12211
2025-04-14 UPLOAD filename1.pdf 0000000000-25-003935 333-286442 40285
2025-04-11 CORRESP filename1.htm 0001641172-25-003761 12068
2025-04-11 8-K form8-k.htm 8.01,9.01 0001641172-25-003741 001-37685 25830225 34 250593 1 1
2025-04-11 S-3/A forms-3a.htm 0001641172-25-003734 333-283994 25830211 33 465962
2025-04-10 S-3/A forms-3a.htm 0001641172-25-003502 333-283994 25826417 33 470490
2025-04-08 S-3 forms-3.htm 0001641172-25-003276 333-286442 25823074 33 646041
2025-03-25 8-K form8-k.htm 2.02,7.01,9.01 0001641172-25-000517 001-37685 25765952 34 372062 1 1
2025-03-24 10-K form10-k.htm 0001641172-25-000364 001-37685 25765147 34 11800761 1 1
2025-03-14 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-25-005532 5196
2025-03-10 8-K form8-k.htm 8.01,9.01 0001493152-25-009698 001-37685 25723882 34 258922 1 1
2025-02-28 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001094891-25-000002 005-89489 25692434 34 15181
2025-02-21 8-K form8-k.htm 3.02,9.01 0001493152-25-007902 001-37685 25652886 34 273504 1 1
2025-02-18 8-K form8-k.htm 8.01,9.01 0001493152-25-007094 001-37685 25632848 34 264739 1 1
2025-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-006358 005-89489 25619021 34 12012
2025-02-07 D xslFormDX01/primary_doc.xml 06b 0001624326-25-000001 021-537717 25602202 33 12763
2025-01-31 S-8 forms-8.htm 0001493152-25-004444 333-284637 25579066 33 162135
2025-01-31 S-8 forms-8.htm 0001493152-25-004443 333-284636 25579065 33 159995
2025-01-24 8-K form8-k.htm 3.01,3.02,3.03,9.01 0001493152-25-003631 001-37685 25555143 34 270862 1 1
2025-01-21 8-K form8-k.htm 3.01,3.02,3.03,5.03,8.01,9.01 0001493152-25-003053 001-37685 25542854 34 718361 1 1
2025-01-15 8-K form8-k.htm 5.03,5.07,9.01 0001493152-25-002398 001-37685 25533428 34 294413 1 1
2025-01-07 DEFA14A formdefa14a.htm 0001493152-25-001250 001-37685 25515568 34 67616
2024-12-26 UPLOAD filename1.pdf 0000000000-24-014272 333-283994 40326
2024-12-20 S-3 forms-3.htm 0001493152-24-051108 333-283994 241568936 33 1380294
2024-12-12 144 xsl144X01/primary_doc.xml 0001950047-24-009771 001-37685 241545996 33 7110
2024-12-12 SC 13D/A formsc13da.htm 0001493152-24-049793 76649
2024-12-09 144 xsl144X01/primary_doc.xml 0001950047-24-009601 001-37685 241536351 33 6408
2024-12-06 144 xsl144X01/primary_doc.xml 0001950047-24-009533 001-37685 241533429 33 5707
2024-12-06 DEF 14A formdef14a.htm 0001493152-24-049070 001-37685 241532471 34 1573340
2024-12-05 144 xsl144X01/primary_doc.xml 0001950047-24-009490 001-37685 241530052 33 5005
2024-11-29 8-K form8-k.htm 1.01,2.03,3.03,9.01 0001493152-24-048173 001-37685 241516575 34 277506 1 1
2024-11-21 PRE 14A formpre14a.htm 0001493152-24-047165 001-37685 241485104 34 1463119
2024-11-21 8-K form8-k.htm 1.01,3.02,3.03,9.01 0001493152-24-047156 001-37685 241484877 34 1538789 1 1
2024-11-14 SC 13G firstmanhattan-pavm093024.htm 0001172661-24-004797 005-89489 241458062 34 57640
2024-11-14 8-K form8-k.htm 2.02,7.01,9.01 0001493152-24-045362 001-37685 241457342 34 376524 1 1
2024-11-14 10-Q form10-q.htm 0001493152-24-045258 001-37685 241456585 34 9089412 1 1
2024-10-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-017897 5274
2024-09-23 SC 13G formsc13g.htm 0001493152-24-037864 005-89489 241317361 34 113929
2024-09-20 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-016841 5277
2024-09-20 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-016839 3921
2024-09-16 8-K form8-k.htm 2.01,3.01,5.02,7.01,9.01 0001493152-24-036380 001-37685 241301067 34 673168 1 1
2024-08-13 8-K form8-k.htm 2.02,7.01,9.01 0001493152-24-031471 001-37685 241198887 34 360262 1 1
2024-08-12 10-Q form10-q.htm 0001493152-24-031268 001-37685 241196827 34 10444257 1 1
2024-06-20 8-K form8-k.htm 5.07,9.01 0001493152-24-024540 001-37685 241057276 34 269332 1 1
2024-05-14 8-K form8-k.htm 2.02,7.01,9.01 0001493152-24-019117 001-37685 24941977 34 337670 1 1
2024-05-13 10-Q form10-q.htm 0001493152-24-018913 001-37685 24939667 34 8691582 1 1
2024-05-07 8-K form8-k.htm 1.01,3.03,9.01 0001493152-24-018036 001-37685 24920000 34 262397 1 1
2024-05-01 8-K form8-k.htm 7.01,9.01 0001493152-24-017324 001-37685 24899754 34 287001 1 1
2024-04-29 DEFA14A formdefa14a.htm 0001493152-24-016966 001-37685 24890813 34 18385916
2024-04-29 ARS formars.pdf 0001493152-24-016953 001-37685 24890578 34 1351773
2024-04-29 DEF 14A formdef14a.htm 0001493152-24-016943 001-37685 24890437 34 1630523
2024-04-26 8-K form8-k.htm 1.01,9.01 0001493152-24-016056 001-37685 24878756 34 254269 1 1
2024-03-25 10-K form10-k.htm 0001493152-24-011172 001-37685 24780243 34 12778251 1 1
2024-03-14 8-K form8-k.htm 1.01,3.03,9.01 0001493152-24-009898 001-37685 24748002 34 262908 1 1
2024-03-14 8-K form8-k.htm 1.01,3.03,9.01 0001493152-24-009894 001-37685 24747966 34 255765 1 1
2024-03-08 8-K form8-k.htm 3.01,9.01 0001493152-24-009411 001-37685 24734867 34 261140 1 1
2024-02-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-004288 9011
2024-02-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-004283 9018
2024-02-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-004282 9015
2024-02-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-004280 8999
2024-02-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-004279 9024
2024-02-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-004277 8999
2024-02-20 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-003693 001-40901 24654358 34 5070
2024-02-20 SC 13D/A formsc13da.htm 0001493152-24-007235 59165
2024-02-16 8-K form8-k.htm 2.01,3.03,8.01,9.01 0001493152-24-006906 001-37685 24645310 34 264452 1 1
2024-02-14 SC 13G formsc13g.htm 0001493152-24-006566 005-89489 24636971 34 180629
2024-02-09 8-K form8-k.htm 8.01,9.01 0001493152-24-005714 001-37685 24615511 34 382367 1 1
2024-02-06 S-8 forms-8.htm 0001493152-24-005128 333-276904 24601231 33 154826
2024-02-06 S-8 forms-8.htm 0001493152-24-005126 333-276903 24601215 33 169234
2024-02-02 SC 13D/A formsc13da.htm 0001493152-24-004790 60338
2024-01-30 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-24-001613 001-40901 24579732 34 5047
2024-01-30 8-K form8-k.htm 8.01,9.01 0001493152-24-004350 001-37685 24579082 34 258683 1 1
2024-01-08 8-K form8-k.htm 8.01,9.01 0001493152-24-001710 001-37685 24520510 34 262796 1 1
2023-12-05 8-K form8-k.htm 3.03,5.03,7.01,9.01 0001493152-23-043666 001-37685 231465309 34 330210 1 1
2023-11-15 8-K form8-k.htm 2.02,7.01,9.01 0001493152-23-041370 001-37685 231408855 34 358596 1 1
2023-11-13 10-Q form10-q.htm 0001493152-23-040620 001-37685 231400026 34 10264540 1 1
2023-10-18 8-K form8-k.htm 1.01,3.03,9.01 0001493152-23-037575 001-37685 231331048 34 259321 1 1
2023-08-14 10-Q form10-q.htm 0001493152-23-028578 001-37685 231171432 34 8271799 1 1
2023-06-28 8-K form8-k.htm 8.01,9.01 0001493152-23-022796 001-37685 231053008 34 259765 1 1
2023-06-21 8-K form8-k.htm 5.07,9.01 0001493152-23-022032 001-37685 231030634 34 267605 1 1
2023-06-06 8-K form8-k.htm 3.02,9.01 0001493152-23-020296 001-37685 23996490 34 259579 1 1
2023-05-30 424B5 form424b5.htm 0001493152-23-019469 333-261814 23976925 33 18993
2023-05-15 10-Q form10-q.htm 0001493152-23-017409 001-37685 23922921 34 7077992 1 1
2023-05-01 DEF 14A formdef14a.htm 0001493152-23-014875 001-37685 23871418 34 1514323
2023-05-01 DEFA14A formdefa14a.htm 0001493152-23-014883 001-37685 23870754 34 862351
2023-05-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-009738 4800
2023-05-01 3/A AMENDED INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-009737 7790
2023-04-19 PRE 14A formpre14a.htm 0001493152-23-012937 001-37685 23831473 34 1585259
2023-04-13 4/A AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-009156 001-40901 23819349 34 11114
2023-04-03 8-K form8-k.htm 7.01,9.01 0001493152-23-010544 001-37685 23790933 34 257676 1 1
2023-03-31 8-K form8-k.htm 5.07,9.01 0001493152-23-010378 001-37685 23788918 34 264156 1 1
2023-03-24 8-K form8-k.htm 1.01,2.03,3.03,9.01 0001493152-23-008940 001-37685 23760864 34 262893 1 1
2023-03-15 8-K form8-k.htm 2.02,7.01,9.01 0001493152-23-007682 001-37685 23733323 34 357759 1 1
2023-03-14 8-K form8-k.htm 1.01,2.03,3.03,9.01 0001493152-23-007632 001-37685 23731991 34 263719 1 1
2023-03-14 10-K form10-k.htm 0001493152-23-007481 001-37685 23728651 34 10127692 1 1
2023-03-13 8-K form8-k.htm 1.01,3.03,9.01 0001493152-23-007473 001-37685 23728296 34 259776 1 1
2023-02-21 DEF 14A formdef14a.htm 0001493152-23-005578 001-37685 23645327 34 1120737
2023-02-17 8-K form8-k.htm 1.02,8.01,9.01 0001493152-23-005455 001-37685 23643105 34 279695 1 1
2023-02-16 8-K form8-k.htm 7.01,9.01 0001493152-23-005332 001-37685 23638909 34 303655 1 1
2023-02-10 S-8 forms-8.htm 0001493152-23-004301 333-269701 23612571 33 155694
2023-02-10 S-8 forms-8.htm 0001493152-23-004300 333-269700 23612573 33 166342
2023-02-08 PRE 14A formpre14a.htm 0001493152-23-003963 001-37685 23599894 34 716114
2023-02-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-002048 5141
2023-02-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-002044 5149
2023-02-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-002043 5127
2023-02-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-002042 5147
2023-02-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-002040 5129
2023-02-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-23-002037 5136
2023-01-18 8-K form8-k.htm 7.01,8.01,9.01 0001493152-23-001722 001-37685 23533007 34 326696 1 1
2022-12-30 8-K form8-k.htm 3.01 0001493152-22-037147 001-37685 221502129 34 257551 1 1
2022-12-07 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-023503 8499
2022-12-02 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-023250 001-40901 221443242 34 10486
2022-12-02 SC 13D/A formsc13da.htm 0001493152-22-034357 84788
2022-12-02 8-K form8-k.htm 8.01 0001493152-22-034354 001-37685 221443066 34 250263 1 1
2022-11-15 8-K form8-k.htm 2.02,7.01,9.01 0001493152-22-032536 001-37685 221392090 34 426104 1 1
2022-11-14 10-Q form10-q.htm 0001493152-22-032037 001-37685 221385341 34 7470227 1 1
2022-09-09 8-K form8-k.htm 2.03,9.01 0001493152-22-025447 001-37685 221235084 34 315873 1 1
2022-08-17 8-K form8-k.htm 2.02,7.01,9.01 0001493152-22-023252 001-37685 221171389 34 493186 1 1
2022-08-15 10-Q form10-q.htm 0001493152-22-023020 001-37685 221167320 34 6626408 1 1
2022-07-08 SC 13G us70387r1068_070822.txt 0000834237-22-010319 005-89489 221075086 34 12226
2022-06-22 8-K form8-k.htm 5.03,5.07,9.01 0001493152-22-017444 001-37685 221030084 34 303287 1 1
2022-06-09 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-014562 5168
2022-06-08 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-014477 2981
2022-05-16 10-Q form10-q.htm 0001493152-22-013965 001-37685 22931056 34 6958803 1 1
2022-05-12 8-K form8-k.htm 2.02,7.01,9.01 0001493152-22-013100 001-37685 22919166 34 391148 1 1
2022-05-02 DEFA14A defa14a.htm 0001493152-22-011738 001-37685 22879693 34 2955063
2022-05-02 DEF 14A def14a.htm 0001493152-22-011735 001-37685 22879676 34 2074451
2022-04-26 8-K form8-k.htm 7.01,9.01 0001493152-22-011245 001-37685 22855306 34 374257 1 1
2022-04-22 PRE 14A pre14a.htm 0001493152-22-010732 001-37685 22845969 34 5234763
2022-04-13 S-8 forms-8.htm 0001493152-22-009821 333-264272 22825005 33 113142
2022-04-13 S-8 forms-8.htm 0001493152-22-009820 333-264271 22825003 33 113187
2022-04-11 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-010064 4678
2022-04-11 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-010063 8192
2022-04-06 10-K form10-k.htm 0001493152-22-009202 001-37685 22809240 34 12072134 1 1
2022-04-04 8-K form8-k.htm 1.01,2.03,7.01,9.01 0001493152-22-009057 001-37685 22803953 34 1672178 1 1
2022-04-04 424B5 form424b5.htm 0001493152-22-009056 333-261814 22803935 33 859689
2022-04-01 8-K form8-k.htm 1.01,9.01 0001493152-22-008850 001-37685 22798956 34 270329 1 1
2022-04-01 NT 10-K formnt10-k.htm 0001493152-22-008796 001-37685 22798188 34 27746
2022-03-29 8-K form8-k.htm 2.02,7.01,9.01 0001493152-22-008057 001-37685 22782007 34 587811 1 1
2022-03-08 8-K form8-k.htm 7.01,9.01 0001493152-22-006249 001-37685 22720406 34 283707 1 1
2022-03-03 8-K form8-k.htm 1.01,2.01,9.01 0001493152-22-005895 001-37685 22706828 34 275770 1 1
2022-03-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-006203 5105
2022-03-01 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-006202 5087
2022-03-01 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-006201 2920
2022-02-24 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-005565 6762
2022-02-24 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-005564 7328
2022-02-24 8-K form8-k.htm 5.02,7.01,9.01 0001493152-22-005399 001-37685 22671142 34 416021 1 1
2022-02-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-005493 5116
2022-02-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-005492 5178
2022-02-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-005489 5118
2022-02-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-005488 5098
2022-02-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-005486 5110
2022-02-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-005484 5197
2022-02-23 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-005481 5179
2022-02-18 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-004927 5079
2022-02-18 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-004924 2911
2022-02-15 8-K form8-k.htm 5.02,7.01,9.01 0001493152-22-004696 001-37685 22639984 34 311336 1 1
2022-02-04 SC 13G us70387r1068_020422.txt 0000834237-22-007202 005-89489 22593528 34 13171
2022-01-28 25-NSE xslF25X02/primary_doc.xml 0001354457-22-000084 001-37685 22568655 34 3018
2022-01-10 424B5 form424b5.htm 0001493152-22-000721 333-261814 22519101 33 468414
2022-01-07 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-01-07 09:30:00 9999999995-22-000091 333-261814 22519509 33 1800
2022-01-05 CORRESP filename1.htm 0001493152-22-000408 9798
2021-12-27 UPLOAD filename1.pdf 0000000000-21-015379 40277
2021-12-21 S-3 forms-3.htm 0001493152-21-032201 333-261814 211510230 33 1878845
2021-11-22 10-Q form10-q.htm 0001493152-21-029625 001-37685 211433743 34 8473492 1 1
2021-11-16 NT 10-Q formnt10-q.htm 0001493152-21-028945 001-37685 211416054 34 40143
2021-11-04 8-K form8-k.htm 2.02,9.01 0001493152-21-027163 001-37685 211377044 34 308552 1 1
2021-10-27 SC 13D formsc13d.htm 0001493152-21-026551 75073
2021-10-25 8-K form8-k.htm 7.01,9.01 0001493152-21-026257 001-37685 211344818 34 304015 1 1
2021-10-20 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-21-009743 001-40901 211334804 34 4637
2021-10-18 8-K form8-k.htm 2.01 0001493152-21-025708 001-37685 211328890 34 269147 1 1
2021-10-13 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-21-009493 001-40901 211322377 34 3876
2021-10-07 8-K form8-k.htm 8.01,9.01 0001493152-21-024892 001-37685 211311239 34 300911 1 1
2021-10-06 SC 13G/A form_sc13ga.htm 0001011438-21-000235 005-89489 211309544 34 47982
2021-08-16 10-Q form10-q.htm 0001493152-21-020273 001-37685 211179914 34 7431680 1 1
2021-08-12 8-K form8-k.htm 2.02,9.01 0001493152-21-019551 001-37685 211168784 34 150597
2021-08-10 8-K form8-k.htm 7.01,9.01 0001493152-21-019119 001-37685 211158691 34 61438
2021-08-04 S-8 forms-8.htm 0001493152-21-018604 333-258459 211144730 33 347588
2021-08-04 S-8 forms-8.htm 0001493152-21-018603 333-258458 211144728 33 122262
2021-08-03 8-K form8-k.htm 7.01,9.01 0001493152-21-018371 001-37685 211138283 34 101499
2021-07-28 8-K form8-k.htm 7.01,9.01 0001493152-21-017939 001-37685 211120035 34 90515
2021-07-23 8-K form8-k.htm 7.01,9.01 0001493152-21-017643 001-37685 211111214 34 62860
2021-06-16 8-K form8-k.htm 5.02,5.07,9.01 0001493152-21-014452 001-37685 211019919 34 61219
2021-06-14 8-K form8-k.htm 5.02,7.01,9.01 0001493152-21-014311 001-37685 211014770 34 71525
2021-06-10 8-K form8-k.htm 7.01,9.01 0001493152-21-014045 001-37685 211008937 34 70494
2021-06-02 8-K form8-k.htm 8.01,9.01 0001493152-21-013452 001-37685 21989965 34 90836
2021-05-26 8-K form8-k.htm 7.01,9.01 0001493152-21-012960 001-37685 21966121 34 71924
2021-05-25 8-K form8-k.htm 7.01,9.01 0001493152-21-012817 001-37685 21958868 34 119673
2021-05-20 S-8 forms-8.htm 0001493152-21-012388 333-256343 21945582 33 379924
2021-05-17 10-Q form10-q.htm 0001493152-21-011853 001-37685 21930817 34 3883173 1
2021-05-17 8-K form8-k.htm 2.02,9.01 0001493152-21-011848 001-37685 21930635 34 139092
2021-05-13 8-K form8-k.htm 7.01,9.01 0001493152-21-011312 001-37685 21920095 34 57251
2021-05-06 8-K form8-k.htm 7.01,9.01 0001493152-21-010631 001-37685 21898313 34 70047
2021-05-03 4 PRIMARY DOCUMENT 0001094891-21-000188 5126
2021-05-03 3 PRIMARY DOCUMENT 0001094891-21-000186 3103
2021-04-30 DEF 14A formdef14a.htm 0001493152-21-010121 001-37685 21873906 34 1306536
2021-04-29 8-K form8-k.htm 7.01,9.01 0001493152-21-010034 001-37685 21871153 34 70104
2021-04-27 8-K form8-k.htm 5.02 0001493152-21-009840 001-37685 21859090 34 36118
2021-04-19 8-K form8-k.htm 7.01,9.01 0001493152-21-009137 001-37685 21834986 34 35698573
2021-04-12 8-K form8-k.htm 8.01 0001493152-21-008550 001-37685 21821136 34 32113
2021-04-05 4 PRIMARY DOCUMENT 0001094891-21-000180 5260
2021-04-05 4 PRIMARY DOCUMENT 0001094891-21-000178 4898
2021-04-05 4 PRIMARY DOCUMENT 0001094891-21-000176 5185
2021-04-05 4 PRIMARY DOCUMENT 0001094891-21-000174 5227
2021-04-05 4 PRIMARY DOCUMENT 0001094891-21-000172 5202
2021-04-05 4 PRIMARY DOCUMENT 0001094891-21-000170 5168
2021-04-05 4 PRIMARY DOCUMENT 0001094891-21-000168 5240
2021-04-05 4 PRIMARY DOCUMENT 0001094891-21-000165 8120
2021-03-19 4 PRIMARY DOCUMENT 0001094891-21-000143 9602
2021-03-15 10-K form10-k.htm 0001493152-21-006002 001-37685 21741691 34 7002764 1
2021-03-05 8-K form8-k.htm 5.02,5.07,9.01 0001493152-21-005489 001-37685 21719323 34 54532
2021-03-03 8-K form8-k.htm 1.02,9.01 0001493152-21-005245 001-37685 21707436 34 53704
2021-02-25 8-K form8-k.htm 8.01,9.01 0001493152-21-004838 001-37685 21680810 34 57273
2021-02-24 8-K form8-k.htm 1.01,8.01,9.01 0001493152-21-004746 001-37685 21675022 34 404471
2021-02-24 424B5 form424b5.htm 0001493152-21-004745 333-248709 21675004 33 943780
2021-02-23 S-3MEF forms-3mef.htm 0001493152-21-004563 333-253384 21663258 33 94621
2021-02-22 424B5 form424b5.htm 0001493152-21-004522 333-248709 21661684 33 980497
2021-02-22 8-K form8-k.htm 2.02,9.01 0001493152-21-004469 001-37685 21658365 34 122121
2021-02-16 8-K form8-k.htm 7.01,9.01 0001493152-21-003844 001-37685 21633362 34 98079
2021-01-27 DEF 14A formdef14a.htm 0001493152-21-001860 001-37685 21556703 34 1214712
2021-01-26 SC 13G/A form_sc13ga-pavmed.htm 0001011438-21-000049 005-89489 21553047 34 47481
2021-01-15 8-K form8-k.htm 5.03,9.01 0001493152-21-001172 001-37685 21532478 34 149107
2021-01-15 PRE 14A formpre14a.htm 0001493152-21-001170 001-37685 21532454 34 1130070
2021-01-08 8-K form8-k.htm 8.01,9.01 0001493152-21-000600 001-37685 21517630 34 57584
2021-01-07 424B5 form424b5.htm 0001493152-21-000455 333-248709 21514375 33 544497
2021-01-06 8-K form8-k.htm 1.01,8.01,9.01 0001493152-21-000276 001-37685 21509213 34 241826
2020-12-22 8-K form8-k.htm 8.01,9.01 0001493152-20-024124 001-37685 201408137 34 52802
2020-12-18 424B5 form424b5.htm 0001493152-20-023931 333-248709 201401031 33 593225
2020-12-18 8-K form8-k.htm 1.01,8.01,9.01 0001493152-20-023884 001-37685 201398156 34 266401
2020-12-14 424B5 form424b5.htm 0001493152-20-023494 333-248709 201385899 33 609221
2020-12-11 8-K form8-k.htm 1.01,8.01,9.01 0001493152-20-023355 001-37685 201382658 34 249853
2020-11-27 4 FORM 4 SUBMISSION 0000899243-20-032252 8357
2020-11-20 4 FORM 4 SUBMISSION 0000899243-20-031786 8357
2020-11-17 8-K form8-k.htm 2.02,9.01 0001493152-20-021853 001-37685 201321471 34 173962
2020-11-06 10-Q form10-q.htm 0001493152-20-020703 001-37685 201295075 34 4432775 1
2020-09-17 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-09-17 09:00:00 9999999995-20-002492 333-248709 201182703 33 1801
2020-09-14 CORRESP filename1.htm 0001493152-20-017745 11479
2020-09-14 UPLOAD filename1.pdf 0000000000-20-008631 40320
2020-09-10 S-3 forms-3.htm 0001493152-20-017563 333-248709 201168956 33 1321317
2020-09-01 S-8 forms-8.htm 0001493152-20-017094 333-248529 201154847 33 122921
2020-08-18 8-K form8-k.htm 2.02,9.01 0001493152-20-016201 001-37685 201113997 34 137980
2020-08-14 10-Q form10-q.htm 0001493152-20-015956 001-37685 201106653 34 4237324 1
2020-08-11 D xslFormDX01/primary_doc.xml 06b 0001493152-20-015224 021-372978 201092128 33 12169
2020-08-06 8-K form8-k.htm 1.01,2.03,3.02,9.01 0001493152-20-014823 001-37685 201080192 34 1094218
2020-07-27 8-K form8-k.htm 5.02,5.03,5.07,9.01 0001493152-20-014017 001-37685 201049028 34 87312
2020-06-17 8-K form8-k.htm 7.01,9.01 0001493152-20-011323 001-37685 20968194 34 59267
2020-06-15 8-K form8-k.htm 7.01,9.01 0001493152-20-011169 001-37685 20963339 34 58171
2020-06-11 8-K form8-k.htm 7.01,9.01 0001493152-20-010975 001-37685 20956349 34 58687
2020-06-11 DEF 14A def14a.htm 0001493152-20-010973 001-37685 20956238 34 3254775
2020-06-03 8-K form8-k.htm 7.01,9.01 0001493152-20-010441 001-37685 20939082 34 63867
2020-06-01 4 FORM 4 0001567619-20-011404 8230
2020-06-01 PRE 14A pre14a.htm 0001493152-20-010217 001-37685 20931199 34 1408385
2020-05-28 10-Q form10-q.htm 0001493152-20-010040 001-37685 20921634 34 3871578 1
2020-05-21 8-K form8-k.htm 2.02,9.01 0001493152-20-009636 001-37685 20902471 34 124582
2020-05-15 8-K form8-k.htm 8.01 0001493152-20-008906 001-37685 20880511 34 37345
2020-05-04 4 PRIMARY DOCUMENT 0001094891-20-000080 5149
2020-05-04 4 PRIMARY DOCUMENT 0001094891-20-000078 5180
2020-05-04 4 PRIMARY DOCUMENT 0001094891-20-000076 5247
2020-05-04 4 PRIMARY DOCUMENT 0001094891-20-000074 5257
2020-05-04 4 PRIMARY DOCUMENT 0001094891-20-000070 5163
2020-05-04 4 PRIMARY DOCUMENT 0001094891-20-000068 5237
2020-05-04 4 PRIMARY DOCUMENT 0001094891-20-000066 9805
2020-05-04 4 PRIMARY DOCUMENT 0001094891-20-000065 4728
2020-05-01 D xslFormDX01/primary_doc.xml 06b 0001493152-20-007538 021-366172 20841279 33 13044
2020-05-01 8-K form8k.htm 1.01,2.03,3.02,9.01 0001493152-20-007500 001-37685 20838677 34 756932
2020-04-28 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-04-28 09:00:00 9999999995-20-000896 333-235335 20827120 33 1800
2020-04-28 424B3 form424b3.htm 0001493152-20-007262 333-235335 20825002 33 239258
2020-04-24 CORRESP filename1.htm 0001493152-20-007062 11189
2020-04-24 10-K/A form10ka.htm 0001493152-20-007055 001-37685 20815183 34 401802
2020-04-21 8-K form8-k.htm 7.01,9.01 0001493152-20-006812 001-37685 20804137 34 60729
2020-04-20 CORRESP filename1.htm 0001493152-20-006775 12121
2020-04-15 CORRESP filename1.htm 0001493152-20-006461 11772
2020-04-14 10-K form10-k.htm 0001493152-20-006405 001-37685 20792044 34 9444877 1
2020-04-09 8-K form8-k.htm 2.02,9.01 0001493152-20-006143 001-37685 20785501 34 176935
2020-04-02 8-K form8-k.htm 7.01,9.01 0001493152-20-005660 001-37685 20767539 34 59288
2020-03-31 8-K form8-k.htm 7.01,9.01 0001493152-20-005413 001-37685 20759893 34 58077
2020-03-30 S-3/A forms-3a.htm 0001493152-20-005215 333-235335 20757250 33 375478
2020-03-30 NT 10-K formnt10-k.htm 0001493152-20-005214 001-37685 20757219 34 42249
2020-03-09 8-K form8-k.htm 7.01,9.01 0001493152-20-003574 001-37685 20696739 34 72723
2020-03-02 CORRESP filename1.htm 0001493152-20-003240 49296
2020-03-02 8-K form8-k.htm 7.01,9.01 0001493152-20-003191 001-37685 20674610 34 73409
2020-02-20 8-K form8-k.htm 7.01,9.01 0001493152-20-002766 001-37685 20632800 34 72877
2020-02-18 UPLOAD filename1.pdf 0000000000-20-001503 43678
2020-02-18 8-K form8k.htm 7.01,9.01 0001493152-20-002639 001-37685 20623813 34 73658
2020-02-14 SC 13G/A form_sc13ga-pavmed.htm 0001011438-20-000095 005-89489 20618590 34 60949
2020-02-11 8-K form8-k.htm 7.01,9.01 0001493152-20-001909 001-37685 20594397 34 69760
2020-02-03 4 FORM 4 0001567619-20-001925 9265
2020-01-30 CORRESP filename1.htm 0001493152-20-001396 73693
2020-01-22 UPLOAD filename1.pdf 0000000000-20-000555 51661
2020-01-13 8-K form8-k.htm 8.01,9.01 0001493152-20-000502 001-37685 20523021 34 57450
2020-01-08 CORRESP filename1.htm 0001493152-20-000374 83667
2019-12-19 UPLOAD filename1.pdf 0000000000-19-016593 52467
2019-12-05 DEL AM formdelam.htm 0001493152-19-018779 333-235335 191270086 33 12344
2019-12-03 S-3 forms-3.htm 0001493152-19-018681 333-235335 191265984 33 408458
2019-11-19 10-Q form10-q.htm 0001493152-19-017989 001-37685 191231279 34 4775971 1
2019-11-15 NT 10-Q nt10-q.htm 0001493152-19-017676 001-37685 191222646 34 41740
2019-11-07 D xslFormDX01/primary_doc.xml 06b 0001493152-19-016564 021-352793 191197502 33 13361
2019-11-04 8-K form8-k.htm 1.01,2.03,3.02,9.01 0001493152-19-016387 001-37685 191190485 34 1849583
2019-10-11 8-K form8-k.htm 3.01 0001493152-19-015418 001-37685 191148296 34 33685
2019-10-03 UPLOAD filename1.pdf 0000000000-19-014244 39470
2019-09-30 10-Q/A form10-qa.htm 0001493152-19-014768 001-37685 191126413 34 89081
2019-09-30 10-Q/A form10-qa.htm 0001493152-19-014763 001-37685 191126363 34 76551
2019-09-30 10-K/A form10-ka.htm 0001493152-19-014761 001-37685 191126334 34 85443
2019-09-30 CORRESP filename1.htm 0001493152-19-014758 23866
2019-09-26 UPLOAD filename1.pdf 0000000000-19-013984 43038
2019-08-14 10-Q form10-q.htm 0001493152-19-012534 001-37685 191026591 34 5474767 1

Latest XBRL company facts

One latest value per concept from companyfacts (385 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 8.00M 2026-11-12 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0.001 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
dei EntityPublicFloat Entity Public Float USD 11.80M 2024-06-30 2025 FY 10-K 2026-03-27 0001437749-26-010115
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 617,658 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001493152-26-020705
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 595,767 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001493152-26-020705
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 992,469 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001493152-26-020705
ecd PeoTotalCompAmt PeoTotalCompAmt USD 1.03M 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001493152-26-020705
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 3 2025-01-01 2025-12-31 DEF 14A 2026-04-30 0001493152-26-020705
ffd NetFeeAmt NetFeeAmt USD 136.72 2026-07-29 S-8 2026-07-30 0001493152-26-035296
ffd TtlFeeAmt TtlFeeAmt USD 136.72 2026-07-29 S-8 2026-07-30 0001493152-26-035296
ffd TtlOfferingAmt TtlOfferingAmt USD 990,000 2026-07-29 S-8 2026-07-30 0001493152-26-035296
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-07-29 S-8 2026-07-30 0001493152-26-035296
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-04-20 S-3 2026-04-21 0001493152-26-018158
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 2.49M 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.04M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 3,000 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 1.03M 2019-12-31 2019 FY 10-K 2020-04-14 0001493152-20-006405
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 20,796 2019-12-31 2019 FY 10-K 2020-04-14 0001493152-20-006405
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 2.55M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 111,249 2016-12-31 2017 FY 10-K 2018-03-14 0001493152-18-003367
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 145,937 2018-12-31 2019 FY 10-K 2020-04-14 0001493152-20-006405
us-gaap AccruedSalariesCurrentAndNoncurrent Accrued Salaries USD 145,937 2018-12-31 2019 FY 10-K 2020-04-14 0001493152-20-006405
us-gaap AccruedVacationCurrent Accrued Vacation, Current USD 28,848 2019-12-31 2019 FY 10-K 2020-04-14 0001493152-20-006405
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.36M 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 299.92M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 40.52M 2019-06-30 2019 Q2 10-Q 2019-08-14 0001493152-19-012534
us-gaap AdjustmentForAmortization Amortization USD 123,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001493152-22-013965
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 766,456 2018-01-01 2018-12-31 2019 FY 10-K 2020-04-14 0001493152-20-006405
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition USD 1.17M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 2.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 1.12M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001493152-18-016081
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 6.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap AssetAcquisitionContingentConsiderationLiabilityCurrent AssetAcquisitionContingentConsiderationLiabilityCurrent USD 1.00M 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-023020
us-gaap Assets Assets USD 35.21M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap AssetsCurrent Assets, Current USD 9.68M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 31.61M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap BusinessAcquisitionProFormaEarningsPerShareBasic Business Acquisition, Pro Forma Earnings Per Share, Basic USD/shares -0.2 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001493152-22-013965
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD -17.13M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001493152-22-013965
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents USD 108,000 2021-05-18 2021 Q3 10-Q 2021-11-22 0001493152-21-029625
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill USD 133,000 2021-05-18 2021 Q3 10-Q 2021-11-22 0001493152-21-029625
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles USD 70,000 2021-05-18 2021 Q3 10-Q 2021-11-22 0001493152-21-029625
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities USD 50,000 2021-05-18 2021 Q3 10-Q 2021-11-22 0001493152-21-029625
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net USD 261,000 2021-05-18 2021 Q3 10-Q 2021-11-22 0001493152-21-029625
us-gaap Cash Cash USD 3.10M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 3.63M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -4.03M 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-15 0001493152-19-007446
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 8.94M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 7.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap CashDivestedFromDeconsolidation Cash Divested from Deconsolidation USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.712 2025-02-18 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 756,734 2025-02-18 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 25.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 6.95M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 6.95M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap CommonStockValue Common Stock, Value, Issued USD 7,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap CompensatedAbsencesLiability Compensated Absences Liability USD 364,583 2015-12-31 2016 FY 10-K 2017-02-16 0001571049-17-001422
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 0 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-13 0001437749-26-027733
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 4.60M 2020-12-31 2021 FY 10-K 2022-04-06 0001493152-22-009202
us-gaap ConvertiblePreferredDividendsNetOfTax Convertible Preferred Dividends, Net of Tax USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001437749-26-027733
us-gaap CostOfGoodsAndServicesSoldAmortization Cost, Amortization USD 6,000 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001493152-21-020273
us-gaap CostOfRevenue Cost of Revenue USD 377,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap CostsAndExpenses Costs and Expenses USD 21.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap CostsAndExpensesRelatedParty Costs and Expenses, Related Party USD 1.16M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0001493152-23-040620
us-gaap CurrentFederalStateAndLocalTaxExpenseBenefit Current Federal, State and Local, Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 10.93M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-15 0001493152-21-006002
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 15.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 0.5 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 6.58M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap DebtInstrumentFairValue Debt Instrument, Fair Value Disclosure USD 14.20M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap DebtInstrumentIssuedPrincipal DebtInstrumentIssuedPrincipal USD 11.11M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment USD 176,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap DebtInstrumentPeriodicPaymentInterest Debt Instrument, Periodic Payment, Interest USD 11.86M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001493152-21-020273
us-gaap DebtInstrumentPeriodicPaymentPrincipal Debt Instrument, Periodic Payment, Principal USD 11.86M 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-06 0001493152-22-009202
us-gaap DebtInstrumentRedemptionPricePercentage Debt Instrument, Redemption Price, Percentage pure 1.325 2026-02-01 2026-02-28 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap DebtInstrumentRepaidPrincipal DebtInstrumentRepaidPrincipal USD 26,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 2.13M 2018-09-30 2018 Q3 10-Q 2018-11-14 0001493152-18-016081
us-gaap DebtInstrumentUnamortizedDiscountNoncurrent Debt Instrument, Unamortized Discount, Noncurrent USD 3.24M 2017-12-31 2018 FY 10-K 2019-04-01 0001493152-19-004603
us-gaap DeconsolidationGainOrLossAmount Deconsolidation, Gain (Loss), Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 5.71M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap DeferredFederalStateAndLocalTaxExpenseBenefit Deferred Federal, State and Local, Tax Expense (Benefit) USD 7.79M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 2.48M 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 111,249 2016-12-31 2017 FY 10-K 2018-03-14 0001493152-18-003367
us-gaap DeferredRevenueAdditions Deferred Revenue, Additions USD 100.00M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-14 0001493152-23-007481
us-gaap DeferredRevenuePeriodIncreaseDecrease Deferred Revenue, Period Increase (Decrease) USD 300,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-14 0001493152-23-007481
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 600,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-14 0001493152-23-007481
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 2.08M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 14,000 2020-12-31 2021 FY 10-K 2022-04-06 0001493152-22-009202
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 36.71M 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap DeferredTaxAssetsGrossNoncurrent Deferred Tax Assets, Gross, Noncurrent USD 3.16M 2016-12-31 2016 FY 10-K 2017-02-16 0001571049-17-001422
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 4.43M 2024-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 249,000 2024-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 27.57M 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration USD 131.10M 2024-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 213.60M 2024-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration USD 13.80M 2024-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 537,000 2023-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 2.62M 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap DeferredTaxAssetsTaxDeferredExpense Deferred Tax Assets, Tax Deferred Expense USD 19,000 2024-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits USD 165,404 2015-12-31 2016 FY 10-K 2017-02-16 0001571049-17-001422
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 3.88M 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 897,000 2021-12-31 2021 FY 10-K 2022-04-06 0001493152-22-009202
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 34.23M 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap DeferredTaxAssetsValuationAllowanceNoncurrent Deferred Tax Assets, Valuation Allowance, Noncurrent USD 3.16M 2016-12-31 2016 FY 10-K 2017-02-16 0001571049-17-001422
us-gaap DeferredTaxLiabilitiesDeferredExpense Deferred Tax Liabilities, Deferred Expense USD 62.30M 2024-09-10 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedPatentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Patent Costs USD 36,000 2021-12-31 2022 FY 10-K 2023-03-14 0001493152-23-007481
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 450,000 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 62.30M 2024-09-10 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 5,000 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap DepositAssets Deposit Assets USD 406,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap Depreciation Depreciation USD 105,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 58,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD -291,000 2023-01-01 2023-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-045258
us-gaap DerivativeLiabilities Derivative Liability USD 291,000 2023-09-30 2023 Q3 10-Q 2023-11-13 0001493152-23-040620
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 291,000 2023-09-30 2023 Q3 10-Q 2023-11-13 0001493152-23-040620
us-gaap DilutiveSecurities Dilutive Securities, Effect on Basic Earnings Per Share USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001437749-26-027733
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 0 2025-04-01 2025-06-30 2026 Q2 10-Q 2026-08-13 0001437749-26-027733
us-gaap DueFromRelatedParties Due from Related Parties USD 27,000 2021-03-31 2021 Q1 10-Q 2021-05-17 0001493152-21-011853
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 25,000 2016-03-31 2016 Q1 10-Q/A 2016-05-20 0001571049-16-015428
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.65 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-06 0001493152-22-009202
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -3.17 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001437749-26-027733
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.376 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap EffectiveIncomeTaxRateReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Percent pure 0.21 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-15 0001493152-19-007446
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.019 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.011 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.022 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsForeign Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent pure 0.018 2016-01-01 2016-12-31 2016 FY 10-K 2017-02-16 0001571049-17-001422
us-gaap EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet Embedded Derivative, Gain (Loss) on Embedded Derivative, Net USD -76,150 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-14 0001493152-17-013216
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 1.20M 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap EquityMethodInvestments Equity Method Investments USD 23.51M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap EquitySecuritiesFvNiGainLoss Equity Securities, FV-NI, Gain (Loss) USD 8.48M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap ExtinguishmentOfDebtGainLossNetOfTax Extinguishment of Debt, Gain (Loss), Net of Tax USD 259,812 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-14 0001493152-19-012534
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -1.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2015-08-01 2015-08-31 2016 FY 10-K 2017-02-16 0001571049-17-001422
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.58 2015-08-01 2015-08-31 2016 FY 10-K 2017-02-16 0001571049-17-001422
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.023 2015-08-01 2015-08-31 2016 FY 10-K 2017-02-16 0001571049-17-001422
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD 3.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 44.00M 2024-06-30 2024 Q2 10-Q 2024-08-12 0001493152-24-031268
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 70,000 2024-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 421,000 2024-06-30 2024 Q2 10-Q 2024-08-12 0001493152-24-031268
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 210,000 2024-06-30 2024 Q2 10-Q 2024-08-12 0001493152-24-031268
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 319,000 2021-12-31 2021 FY 10-K 2022-04-06 0001493152-22-009202
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 315,000 2022-12-31 2022 FY 10-K 2023-03-14 0001493152-23-007481
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 315,000 2023-12-31 2023 FY 10-K 2024-03-25 0001493152-24-011172
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 316,000 2024-06-30 2024 Q2 10-Q 2024-08-12 0001493152-24-031268
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 70,000 2024-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 1.42M 2023-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap GainLossOnDispositionOfIntangibleAssets Gain (Loss) on Disposition of Intangible Assets USD 1.00M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -3.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost USD -3.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap GainsLossesOnRestructuringOfDebt Gains (Losses) on Restructuring of Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 15.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap GovernmentAssistanceNonoperatingIncome GovernmentAssistanceNonoperatingIncome USD 579,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap GrossProfit Gross Profit USD -180,000 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-023020
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -20.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -22.78M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-16 0001493152-21-020273
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -7.44M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-14 0001493152-19-012534
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares -0.42 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029625
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability Income Tax Expense (Benefit), Continuing Operations, Adjustment of Deferred Tax (Asset) Liability USD -7.79M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 10.69M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -518,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 27,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 390,000 2023-11-01 2023-11-30 2023 FY 10-K 2024-03-25 0001493152-24-011172
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 358,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 16,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 1.92M 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-06 0001493152-22-009202
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 5.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap IncreaseDecreaseInDeposits Increase (Decrease) in Deposits USD -643,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-04-14 0001493152-20-006405
us-gaap IncreaseDecreaseInDueFromRelatedPartiesCurrent Increase (Decrease) in Due from Related Parties, Current USD 25,000 2016-01-01 2016-03-31 2016 Q1 10-Q/A 2016-05-20 0001571049-16-015428
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD -1.76M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0001493152-22-013965
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 944,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD -109,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap IncreaseDecreaseInRoyaltiesPayable Increase (Decrease) in Royalties Payable USD 150,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029625
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-14 0001437749-26-017121
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001437749-26-027733
us-gaap IncrementalCommonSharesAttributableToConversionOfPreferredStock Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock shares 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001437749-26-027733
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001437749-26-027733
us-gaap IntangibleAssetsCurrent Intangible Assets, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 1.42M 2023-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap InterestAndDebtExpense Interest and Debt Expense USD 201,867 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001493152-18-016081
us-gaap InterestExpense Interest Expense USD 26,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap InterestExpenseDebt Interest Expense, Debt USD 16,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 10,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 591,574 2018-01-01 2018-12-31 2018 FY 10-K 2019-04-01 0001493152-19-004603
us-gaap InterestIncomeOperating Interest Income, Operating USD 24,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap InterestPayableCurrent Interest Payable, Current USD 201,867 2018-09-30 2018 Q3 10-Q 2018-11-14 0001493152-18-016081
us-gaap InventoryNet Inventory, Net USD 278,000 2023-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 36,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 2.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 1,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-21 0001493152-18-007612
us-gaap LeaseCost Lease, Cost USD 756,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 2.10M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 0 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 594,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 367,000 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 367,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 481,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 471,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 182,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 272,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap Liabilities Liabilities USD 25.08M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 35.21M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 272,356 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-14 0001493152-17-013216
us-gaap LiabilitiesCurrent Liabilities, Current USD 23.80M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 6.90M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 2.18M 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-023020
us-gaap LitigationSettlementAmountAwardedToOtherParty Litigation Settlement, Amount Awarded to Other Party USD 450,000 2020-11-01 2020-11-02 2022 FY 10-K 2023-03-14 0001493152-23-007481
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 174,000 2024-09-30 2024 Q3 10-Q 2024-11-14 0001493152-24-045258
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 100,000 2020-09-30 2020 Q3 10-Q 2020-11-06 0001493152-20-020703
us-gaap LossContingencyDamagesAwardedValue Loss Contingency, Damages Awarded, Value USD 1.30M 2020-12-22 2020-12-23 2021 Q3 10-Q 2021-11-22 0001493152-21-029625
us-gaap MarketableSecurities Marketable Securities USD 35.00M 2018-03-05 2018 Q1 10-Q 2018-05-21 0001493152-18-007612
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD -17.33M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders USD 7.50M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap MinorityInterestDecreaseFromRedemptions Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001437749-26-027733
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 10.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 4.30M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-21 0001493152-18-007612
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -43,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -5,301 2017-01-01 2017-03-31 2018 Q1 10-Q 2018-05-21 0001493152-18-007612
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -2.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -2.20M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-21 0001493152-18-007612
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -17.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -3.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -24.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -24.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap NoncontrollingInterestDecreaseFromDeconsolidation Noncontrolling Interest, Decrease from Deconsolidation USD 56.34M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap NoncontrollingInterestIncreaseFromBusinessCombination Noncontrolling Interest, Increase from Business Combination USD 7.50M 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD 353,000 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 1.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap NotesPayableCurrent Notes Payable, Current USD 300,000 2020-12-31 2021 FY 10-K 2022-04-06 0001493152-22-009202
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029625
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap OperatingExpenses Operating Expenses USD 42.93M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-15 0001493152-22-023020
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -21.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap OperatingLeaseCost Operating Lease, Cost USD 692,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 1.82M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 535,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 1.29M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap OperatingLeasePayments Operating Lease, Payments USD 542,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 1.60M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.079 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 144.90M 2024-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.75M 2022-12-31 2022 FY 10-K 2023-03-14 0001493152-23-007481
us-gaap OtherAssets Other Assets USD 724,000 2020-09-30 2020 Q3 10-Q 2020-11-06 0001493152-20-020703
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 52,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 769,000 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap OtherNoncashExpense Other Noncash Expense USD 8,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 11,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -41,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap PaymentsForRent Payments for Rent USD 2.60M 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-12 0001493152-24-031268
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 101,098 2019-01-01 2019-12-31 2019 FY 10-K 2020-04-14 0001493152-20-006405
us-gaap PaymentsForRepurchaseOfConvertiblePreferredStock Payments for Repurchase of Convertible Preferred Stock USD 7,099 2018-01-01 2018-12-31 2019 FY 10-K 2020-04-14 0001493152-20-006405
us-gaap PaymentsForRepurchaseOfInitialPublicOffering Payments for Repurchase of Initial Public Offering USD 5.67M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-14 0001493152-23-007481
us-gaap PaymentsForRepurchaseOfPreferredStockAndPreferenceStock Payments for Repurchase of Preferred Stock and Preference Stock USD 26.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.31M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-14 0001493152-23-007481
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 3.20M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-25 0001493152-24-011172
us-gaap PaymentsToAcquireProductiveAssets Payments to Acquire Productive Assets USD 3.20M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-14 0001493152-23-007481
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 43,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 265,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap PreferredStockNoParValue Preferred Stock, No Par Value USD/shares 3 2022-12-31 2022 FY 10-K 2023-03-14 0001493152-23-007481
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 20.00M 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 422,838 2017-06-30 2017 Q2 10-Q 2017-08-11 0001493152-17-008973
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 422,838 2017-06-30 2017 Q2 10-Q 2017-08-11 0001493152-17-008973
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 3.32M 2024-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 1.02M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 1.02M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap PrepaidInsurance Prepaid Insurance USD 245,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 3.70M 2020-01-01 2020-12-31 2021 FY 10-K 2022-04-06 0001493152-22-009202
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 2.37M 2025-02-21 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 7.00M 2018-01-01 2018-12-31 2018 FY 10-K 2019-04-01 0001493152-19-004603
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 7.50M 2017-01-01 2017-12-31 2018 Q1 10-Q 2018-05-21 0001493152-18-007612
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 29.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 2.10M 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-10 0001571049-16-019749
us-gaap ProceedsFromIssuanceOfSecuredDebt Proceeds from Issuance of Secured Debt USD 15.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 5,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-04-06 0001493152-22-009202
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 272,357 2015-08-01 2015-08-31 2016 FY 10-K 2017-02-16 0001571049-17-001422
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 300,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-04-06 0001493152-22-009202
us-gaap ProceedsFromPartnershipContribution Proceeds from Partnership Contribution USD 1,812 2018-01-01 2018-12-31 2018 FY 10-K 2019-04-01 0001493152-19-004603
us-gaap ProceedsFromSaleOfPropertyHeldForSale Proceeds from Sale of Property Held-for-sale USD 1.00M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 4,000 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 7.80M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-14 0001493152-23-007481
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -20.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.44M 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 62,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 31,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 988,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029625
us-gaap RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty Related Party Transaction, Expenses from Transactions with Related Party USD 114,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029625
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 176,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap RepaymentsOfDebt Repayments of Debt USD 6.06M 2019-01-01 2019-12-31 2019 FY 10-K 2020-04-14 0001493152-20-006405
us-gaap RepaymentsOfSecuredDebt Repayments of Secured Debt USD 11.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 5.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 133,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-14 0001493152-23-007481
us-gaap RestrictedCash Restricted Cash USD 5.30M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 300,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -276.41M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 96,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 612,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-14 0001493152-23-028578
us-gaap Revenues Revenues USD 3.00M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap RoyaltyExpense Royalty Expense USD 23,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-14 0001493152-23-007481
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 5 2015-08-31 2016 FY 10-K 2017-02-16 0001571049-17-001422
us-gaap SecuredDebt Secured Debt USD 20.22M 2020-09-30 2020 Q3 10-Q 2020-11-06 0001493152-20-020703
us-gaap SecuredDebtCurrent Secured Debt, Current USD 14.20M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap SecuredLongTermDebt Secured Long-term Debt, Noncurrent USD 15.10M 2026-06-30 2026 Q2 10-Q 2026-08-13 0001437749-26-027733
us-gaap SecurityDeposit Security Deposit USD 262,000 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 636,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 2.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments USD 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029625
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.76 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029625
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.009 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-22 0001493152-21-029625
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 2.50M 2025-06-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 3,603 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 297,584 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 1.91M 2018-03-31 2018 Q1 10-Q 2018-05-21 0001493152-18-007612
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 3.36 2018-03-31 2018 Q1 10-Q 2018-05-21 0001493152-18-007612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 339,815 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 41.02 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 36,250 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 330.93 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 1.11M 2017-09-30 2017 Q3 10-Q 2017-11-14 0001493152-17-013216
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 5.23 2017-09-30 2017 Q3 10-Q 2017-11-14 0001493152-17-013216
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 1,133.83 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 5.94 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 0.58 2025-07-16 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap SharePrice Share Price USD/shares 1.07 2026-06-30 2026 Q2 10-Q 2026-08-13 0001437749-26-027733
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 27.45M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 10.12M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap StockIssuedDuringPeriodSharesConversionOfUnits Stock Issued During Period, Shares, Conversion of Units shares 400 2025-01-01 2025-03-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 306,555 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-15 0001493152-21-006002
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 1.00M 2025-01-01 2025-03-31 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 263,683 2024-01-01 2024-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures shares 233,334 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-15 0001493152-21-006002
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 260,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 62,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 2.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 16.39M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001437749-26-027733
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 53.70M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-14 0001493152-23-007481
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD -1,000 2022-01-01 2022-09-30 2023 Q3 10-Q 2023-11-13 0001493152-23-040620
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 1.02M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-19 0001493152-19-017989
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 302,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-25 0001493152-24-011172
us-gaap StockIssuedDuringPeriodValueTreasuryStockReissued Stock Issued During Period, Value, Treasury Stock Reissued USD -548,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-25 0001493152-24-011172
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD 26.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap Supplies Prepaid Supplies USD 168,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 3.26M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0.001 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 20.00M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001493152-25-022017
us-gaap TreasuryStockValue Treasury Stock, Value USD 408,000 2022-12-31 2023 FY 10-K 2024-03-25 0001493152-24-011172
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -10.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -7.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap VariableLeaseCost Variable Lease, Cost USD 64,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-27 0001437749-26-010115
us-gaap WarrantExercisePriceDecrease Warrant, Exercise Price, Decrease USD/shares 0.52 2024-02-14 2024-02-15 2024 FY 10-K 2025-03-24 0001641172-25-000364
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 11.69M 2026-03-27 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 3.94M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001437749-26-027733
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 77.52M 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-06 0001493152-22-009202
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 4.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001437749-26-037174
us-gaap WriteOffOfDeferredDebtIssuanceCost Write off of Deferred Debt Issuance Cost USD 550,254 2019-01-01 2019-12-31 2019 FY 10-K 2020-04-14 0001493152-20-006405

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →